Sanjivani Paranteral Ltd vs Vaishali Pharma Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 04, 2026

Key Highlights

The Latest Trading Price of Sanjivani Paranteral Ltd is ₹ 168.9 as of 04 May 10:08 . The P/E Ratio of Sanjivani Paranteral Ltd is 28.4 as of March 2024 .The P/E Ratio of Vaishali Pharma Ltd is 0 as of March 2024 . The Market Cap of Sanjivani Paranteral Ltd is ₹ 175.32 crore as of March 2024 .The Market Cap of Vaishali Pharma Ltd is ₹ 0 crore as of March 2024 . The revenue of Sanjivani Paranteral Ltd for the Mar '25 is ₹ 18.61 crore as compare to the Dec '25 revenue of ₹ 22.36 crore. This represent the decline of -16.77% The revenue of Vaishali Pharma Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 25.54 crore. This represent the decline of -100% The ebitda of Sanjivani Paranteral Ltd for the Mar '25 is ₹ 3.04 crore as compare to the Dec '25 ebitda of ₹ 4.13 crore. This represent the decline of -26.39% The ebitda of Vaishali Pharma Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ 2.45 crore. This represent the decline of -100% The net profit of Sanjivani Paranteral Ltd changed from ₹ 1.71 crore to ₹ 2.19 crore over 7 quarters. This represents a CAGR of 15.19% The net profit of Vaishali Pharma Ltd changed from ₹ 1.28 crore to ₹ 0 crore over 4 quarters. This represents a CAGR of -100.00% The Dividend Payout of Sanjivani Paranteral Ltd changed from 7.33 % on March 2025 to 7.33 % on March 2025 . This represents a CAGR of 0.00% over 1 yearsThe Dividend Payout of Vaishali Pharma Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Sanjivani Paranteral Ltd

Sanjivani Paranteral Limited is a WHO-GMP certified core pharmaceutical company and a pioneer in the manufacturing of injectables and oral solids with an extensive experience spanning two-and-a-half-decades.
The Company primarily focus on life-saving drugs and has exports to over 25 countries, while catering to the needs of a vast geographic area through two WHO-GMP certified manufacturing facilities in Mumbai and Dehradun. Incorporated as a Public Limited Company in October, 1994, Sanjivani Parenteral was jointly promoted by Anami H Khemka and a team of professionals in various fields of pharmaceutical industry.
The Company is involved in the manufacturing of pharmaceutical medicines.
Its products includes oral solids, small volume parenteral and sterile powder formulations. The company is setting up a plant at Taloja, Maharashtra, to manufacture high grade anti-biotics and life saving injectibles used in various infections, pre- and post-operative.

About Vaishali Pharma Ltd

Vaishali Pharma Limited was originally incorporated as a Private Limited Company with the name 'Vaishali Pharma Private Limited' on 25th, April 2008.
On July 01, 2008 the Company acquired the business of proprietorship concerns of its Promoter Mr. Atul Vasani viz.
M/s.
Vaishali Pharmachem through Business Assignment agreement.
Consequently, the business of said Proprietorship Firm merged into Vaishali Pharma Private Limited.

FAQs for the comparison of Sanjivani Paranteral Ltd and Vaishali Pharma Ltd

Which company has a larger market capitalization, Sanjivani Paranteral Ltd or Vaishali Pharma Ltd?

Market cap of Sanjivani Paranteral Ltd is 196 Cr while Market cap of Vaishali Pharma Ltd is 99 Cr

What are the key factors driving the stock performance of Sanjivani Paranteral Ltd and Vaishali Pharma Ltd?

The stock performance of Sanjivani Paranteral Ltd and Vaishali Pharma Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Sanjivani Paranteral Ltd and Vaishali Pharma Ltd?

As of May 4, 2026, the Sanjivani Paranteral Ltd stock price is INR ₹160.0. On the other hand, Vaishali Pharma Ltd stock price is INR ₹7.61.

How do dividend payouts of Sanjivani Paranteral Ltd and Vaishali Pharma Ltd compare?

To compare the dividend payouts of Sanjivani Paranteral Ltd and Vaishali Pharma Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.